Thursday, April 7th, 2016 adds Dementia Pipeline market research 2016 to its database, providing in-depth, high quality, transparent and market-driven, expert’s analysis

Companies Profile discussed in this research: Adamas Pharmaceuticals, Inc., AgeneBio Inc., Alector LLC, AlzProtect SAS, Amarantus Bioscience Holdings, Inc., Axon Neuroscience SE, Axovant Sciences Ltd., BioArctic Neuroscience AB, Biogen, Inc., Biotie Therapies Corp., Boehringer Ingelheim GmbH, Chase Pharmaceuticals Corporation, Daewoong Pharmaceutical Co., Ltd., Eisai Co., Ltd., FORUM Pharmaceuticals Inc., H. Lundbeck A/S, Heptares Therapeutics Limited, Hyundai Pharmaceutical Co., Ltd., Ildong Pharmaceutical Co., Ltd., Immungenetics AG, ImStar Therapeutics Inc., Integrative Research Laboratories Sweden AB, Intellect Neurosciences, Inc., Intra-Cellular Therapies, Inc., MediPost Co., Ltd., Neuraltus Pharmaceuticals, Inc., Neurimmune Holding AG, Neurodyn Inc., Oryzon Genomics S.A., Ovid Therapeutics Inc., P2D Bioscience, Pacific Northwest Biotechnology, LLC, Pivot Pharmaceuticals Inc, Sinil Pharmaceutical Co., Ltd, Stelic Institute & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Sylentis S.A.U., TauRx Therapeutics Ltd. and WhanIn Pharmaceutical Co., Ltd.

Inquire more about this research @

The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dementia and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Complete research across 219 pages



  • The report provides a snapshot of the global therapeutic landscape of Dementia
  • The report reviews pipeline therapeutics for Dementia by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Dementia therapeutics and enlists all their major and minor projects
  • The report assesses Dementia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Dementia.

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Dementia
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Dementia pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

File Library

Contact Profile

RnR Market Research

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus:



RSS / Feeds:

Ritesh Tiwari
P: + 1 888 391 5441


Dementia Therapeutic Products under Development, Key Players in Dementia Therapeutics, Dementia Pipeline Overview, Dementia Pipeline, Dementia Pipeline Assessment




More Formats

View QR Code